FR2364654A1 - Composition antibiotique contenant un derive solide de la cephalosporine et un sel de l'acide carbonique - Google Patents

Composition antibiotique contenant un derive solide de la cephalosporine et un sel de l'acide carbonique

Info

Publication number
FR2364654A1
FR2364654A1 FR7726356A FR7726356A FR2364654A1 FR 2364654 A1 FR2364654 A1 FR 2364654A1 FR 7726356 A FR7726356 A FR 7726356A FR 7726356 A FR7726356 A FR 7726356A FR 2364654 A1 FR2364654 A1 FR 2364654A1
Authority
FR
France
Prior art keywords
composition containing
carbonic acid
antibiotic composition
cephalosporin
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7726356A
Other languages
English (en)
French (fr)
Other versions
FR2364654B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FR2364654A1 publication Critical patent/FR2364654A1/fr
Application granted granted Critical
Publication of FR2364654B1 publication Critical patent/FR2364654B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7726356A 1976-08-31 1977-08-30 Composition antibiotique contenant un derive solide de la cephalosporine et un sel de l'acide carbonique Granted FR2364654A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10458276A JPS5329936A (en) 1976-08-31 1976-08-31 Antibiotic composition

Publications (2)

Publication Number Publication Date
FR2364654A1 true FR2364654A1 (fr) 1978-04-14
FR2364654B1 FR2364654B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-07-03

Family

ID=14384418

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7726356A Granted FR2364654A1 (fr) 1976-08-31 1977-08-30 Composition antibiotique contenant un derive solide de la cephalosporine et un sel de l'acide carbonique

Country Status (8)

Country Link
US (2) US4161527A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5329936A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1109795A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH638680A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2738712A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2364654A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1591654A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL189335C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006011A1 (en) * 1978-06-02 1979-12-12 Takeda Chemical Industries, Ltd. Cephalosporins and pharmaceutical compositions containing them

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1259A1 (fr) * 1978-05-30 1980-01-14 Hoffmann La Roche Derives acyles
ES525492A0 (es) * 1982-09-10 1985-02-01 Glaxo Group Ltd Un procedimiento para la produccion de un recipiente hermeticamente cerrado que contiene al menos un antibiotico de beta-lactama.
JPH0732743Y2 (ja) * 1984-04-20 1995-07-31 株式会社河合楽器製作所 防音室の床構造
JPS6292670U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1985-12-02 1987-06-13
US5227157A (en) * 1986-10-14 1993-07-13 Board Of Regents, The University Of Texas System Delivery of therapeutic agents
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
US4933334A (en) * 1987-12-04 1990-06-12 Takeda Chemical Industries, Ltd. Antibiotic composition
JPH0227569U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1988-08-10 1990-02-22
JPH0492671U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1990-12-28 1992-08-12
JPH07215875A (ja) * 1994-01-27 1995-08-15 Taiyo Yakuhin Kogyo Kk 安定な塩酸セフォチアム製剤
JP5109918B2 (ja) * 2001-10-03 2012-12-26 ニプロ株式会社 複室容器製剤
TWI344847B (en) * 2003-04-28 2011-07-11 Takeda Chemical Industries Ltd Composition for injection
WO2006003151A1 (en) * 2004-06-30 2006-01-12 Dsm Ip Assets B.V. Product comprising a beta-lactam antibiotic
TW200732292A (en) * 2006-02-01 2007-09-01 Shell Int Research A method of treating an aldehyde mixture, use of the treated aldehyde, and an alcohol
RU2545810C2 (ru) 2008-02-29 2015-04-10 Ферросан Медикал Дивайсиз А/С Устройство для ускорения остановки кровотечения и/или заживления ран
CN101569628B (zh) 2009-06-19 2011-05-18 山东罗欣药业股份有限公司 一种盐酸头孢甲肟组合物粉针及其制备方法
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
CN104349797B (zh) 2012-06-12 2017-10-27 弗罗桑医疗设备公司 干止血组合物
WO2014202760A2 (en) 2013-06-21 2014-12-24 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
CA2928963C (en) 2013-12-11 2020-10-27 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
WO2016058612A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
RU2717356C2 (ru) 2015-07-03 2020-03-23 Ферросан Медикал Дивайсиз А/С Шприц для удерживания вакуума в состоянии хранения
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035118A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1969-03-20 1970-12-18 Pfizer
FR2124499A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1971-02-05 1972-09-22 Squibb & Sons Inc
FR2261772A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1974-02-22 1975-09-19 Lilly Co Eli

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57873B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1973-12-25 1982-01-08

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2035118A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1969-03-20 1970-12-18 Pfizer
FR2124499A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1971-02-05 1972-09-22 Squibb & Sons Inc
FR2261772A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1974-02-22 1975-09-19 Lilly Co Eli

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006011A1 (en) * 1978-06-02 1979-12-12 Takeda Chemical Industries, Ltd. Cephalosporins and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
JPS5636174B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-08-22
CA1109795A (en) 1981-09-29
CH638680A5 (de) 1983-10-14
US4161527A (en) 1979-07-17
NL189335C (nl) 1993-03-16
US4241057A (en) 1980-12-23
NL189335B (nl) 1992-10-16
DE2738712A1 (de) 1978-03-02
GB1591654A (en) 1981-06-24
DE2738712C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-01-21
FR2364654B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1981-07-03
NL7709615A (nl) 1978-03-02
JPS5329936A (en) 1978-03-20

Similar Documents

Publication Publication Date Title
FR2364654A1 (fr) Composition antibiotique contenant un derive solide de la cephalosporine et un sel de l'acide carbonique
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
ATE88899T1 (de) Wundheilung und knochenregeneration.
ATE172726T1 (de) 7-(2-aminoethyl)-benzothiazolone
ATE102930T1 (de) Heterozyklische verbindungen, deren herstellung und medikamente diese enthaltend.
JPS54157564A (en) Imidazoo*2*11b***1*3*4**thiadiazoles* their manufacture and use
DE59002863D1 (de) Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
HUT45230A (en) Process for producing new phenoxy-acetic acid derivatives and pharmaceuticals comprising such compounds
IL81106A (en) Antibiotic composition containing a 40926 n-acyl-aminoglucuronyl aglycon and a 40926 aglycon,process for their preparation and pharmaceutical compositions containing them
NO932947L (no) Antimikrobielt middel
GB1370973A (en) Therapeutic compositions
BG101570A (bg) Производни на еритромицин а 9-0-оксим, притежаващи антибиотична активност
ES2019840A6 (es) Procedimiento para preparar nuevos derivados de tieno-triazolo-diazepina.
ATE99934T1 (de) Heteroaryl-3-oxo-propannitril-derivate, nuetzlich zur behandlung von rheumatoider arthritis und anderen autoimmunkrankheiten.
PT81576A (en) Process for the preparation of mercaptane derivatives and of pharmaceutical compositions containing the same
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
HUT41025A (en) Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients
DE3480841D1 (de) Biologisch aktive heptapeptide, mittel, die diese enthalten und anwendungsverfahren.
ATE43598T1 (de) Verbindungen mit aktivitaet gegen aggregation von blutplaettchen, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
DK220088D0 (da) Thiadiasolguanidiner, fremgangsmaade til fremstilling deraf og afrmaceutiske praeparater indeholdende disse forbindelser
ES8104285A1 (es) Un procedimiento para la obtencion de un derivado del acido clarulanico.